Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dako, Amgen to develop new diagnostic test for cancer therapy
In January 2012, Dako has entered into a contract with Amgen introducing a new business model which supports the concurrent development of drug and diagnostics for a rare
In January 2012, Dako has entered into a contract with Amgen introducing a new business model which supports the concurrent development of drug and diagnostics for a rare
Sandoz Canada said it would shift production at the plant to medically necessary products, the globe and mail reported. The company did not clarify the impacted drugs and
Hospira believes that it can increase its supply to the market if it can secure additional methotrexate active ingredient supply. Hospira increased production of the drug to make
TriCore will offer the 4medica Ambulatory Cloud Integrated Electronic Health Record (4medica iEHR(R)) to approximately 4,700 physicians in the state of New Mexico, US. iEHR solution’s bi-directional connectivity
The acquisition is expected to expand Catalent’s development & clinical services business and enhance its position in development solutions and advanced delivery technologies for drugs, biologics, and consumer
Zolpidem tartrate tablets 5mg/10mg [DSP] are film-coated tablets containing 5mg or 10mg of zolpidem tartrate, with a score line on one side, which are indicated for the treatment
The miRInform Pancreas was developed to diagnose and manage pancreatic ductal adenocarcinoma (PDAC) when cytology is inconclusive. Astudy showed that miRInform pancreas test was able to resolve over
Par has paid $20.5m at closing of the acquisition and $4.4m repayment of certain pre-close indebtedness, the companies said. At the closing, a lawsuit filed by a former
The collaboration initially focuses on treating critical limb ischemia, an advanced form of peripheral artery disease. Medistem will provide ERC stem cells for research use and Shanghai Jia
Infants’ TYLENOL is an over-the-counter (OTC) product indicated as a pain reliever/fever reducer. The company has received a small number of complaints from consumers who reported difficulty using